TRANSITION TO HOSPITAL DISCHARGE IN INSULINIZED PATIENTS WITH TYPE 2 DIABETES MELLITUS

Launched by INSTITUTO DE INVESTIGACION SANITARIA LA FE · Jul 2, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at whether using special technology can help people with type 2 diabetes who start insulin treatment while in the hospital manage their condition better once they go home. When patients leave the hospital, it can be hard to remember to take insulin correctly, which is important to keep blood sugar levels steady and avoid problems. This study compares two groups: one group will use a continuous glucose monitor (a small device that tracks blood sugar all day) and a smart insulin pen cap that records insulin doses and reminds patients when to take them. The other group will use these devices too, but won’t see the real-time data and will rely on the usual finger-prick blood sugar tests done four times daily.

The study is for adults aged 18 to 70 who have type 2 diabetes and are starting insulin treatment during a hospital stay. Participants will be followed for 12 weeks after leaving the hospital, with check-ins at several points to review their progress and adjust treatment if needed. The main goals are to see if the technology helps people take their insulin on time, improves blood sugar control, and reduces unexpected hospital visits. About 80 patients will take part at a hospital in Valencia, Spain. This research is important because it could show new ways to support patients during the tricky time when they move from hospital care back to managing diabetes on their own.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults aged 18 to 70 years.
• • Hospitalized patients with a diagnosis of type 2 diabetes mellitus (T2DM), either newly diagnosed during admission or previously known but not previously treated with insulin.
• • Initiation of insulin therapy (basal, basal-plus, or basal-bolus regimen) during hospitalization, with planned continuation post-discharge.
• • Independent in basic activities of daily living.
• • Adequate cognitive and functional capacity to manage the required devices: insulin pen, glucometer, continuous glucose monitoring (CGM) sensor, and Insulclock® cap.
• Exclusion Criteria:
• • Dependence in basic activities of daily living.
• • Any medical condition or functional limitation precluding the use of the CGM or the Insulclock® system.
• • Pregnancy or intention to become pregnant.
• • Diagnosis of type 1 diabetes mellitus.
• • Patients undergoing dialysis.